« Back to Record
Kirschbrown, W. W., Kågedal, M., Wang, B., Lindbom, L., Knott, A., Mack, R., Monemi, S., Nijem, I., Girish, S., Freeman, C., Fumagalli, D., McConnell, R., Jerusalem, G., Twelves, C., Baselga, J., Von Minckwitz, G., Bines, J., & Garg, A. X. (2019). Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study. Cancer chemotherapy and pharmacology, 83(6), 1147-1158. doi:10.1007/s00280-019-03826-1
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/290293



